| Patient | Sarah Walker |
|---|---|
| Date of birth | 1867-12-23 |
| Identifiers | MRN HR-ET019-SYN-TD; SSN (made up) 000-19-7062 |
| Document date | 1917-02-23 |
| Author | Desmond Achterberg, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Albumin in the urine (286 mg/g) and an eGFR of 54 by the race-free CKD-EPI 1912 equation in a 49-year-old woman with high blood pressure readings awaiting ambulatory confirmation, left ventricular hypertrophy on ECG and protein on a dipstick a year ago. Please advise on the cause, any further tests, kidney-protective treatment and her blood pressure target, APOL1 testing, and a monitoring plan that fits a schedule of travel most weeks. [S]
Urgency: Within two weeks, on the day of her two-week visit, so that she makes one trip. [S]
Questions for the consultant:
Madam Walker, 49, is seen at the request of Dr. Okonjo-Bell on the day of her two-week visit. She asked to be addressed as Madam Walker. Her ambulatory monitor showed a 24-hour mean of 149/94, daytime 154/98 and night 140/88, and her home readings average 152/96. Her office has sent last year's executive physical: creatinine 1.18 mg/dL and protein 1+ on a dipstick. She has had morning headaches on some days. She has no visible blood in the urine, no foamy urine she has noticed, no swelling, rash, joint pain, mouth ulcers or kidney stones, and takes no NSAIDs, supplements or herbal products. No known family kidney disease; both parents died when she was a child. She asked plainly whether she will need dialysis and said she would take whatever medicines were needed but would not give up her travel. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
4 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Losartan 50 mg oral tablet, one tablet each morning | One tablet each morning, at the same home time when traveling | Oral route | 1917-02-23 to 1917-03-09 | completed | S |
| Empagliflozin 10 mg oral tablet, one tablet each morning; stop on days of vomiting, diarrhea or not eating, and before surgery | One tablet each morning, with sick-day rules | Oral route | 1917-02-23 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1917-02-23 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Elevated blood pressure at intake (166/102 mmHg, average of two readings), first found at a workplace screening; ambulatory monitoring to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks. |
| Albumin in the urine (urine albumin-to-creatinine ratio 286 mg/g) with eGFR 54 by the race-free CKD-EPI 1912 equation; she recalls protein in the urine at an executive physical a year ago, and those records are requested; to be repeated and investigated | resolved | confirmed | R80.9 | S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks. |
| Hypertension, stage 2, confirmed by 24-hour ambulatory monitoring (24-hour mean 149/94, daytime 154/98, night 140/88 without the normal nighttime fall), with left ventricular hypertrophy on ECG and mild hypertensive retinopathy; synthetic modern episode linked to her documented high blood pressure | active | confirmed | I12.9 | S — Synthetic modern diagnosis anchored to the documented hypertension and nephritis. |
| Chronic kidney disease G3a A2 (eGFR 54 to 55 mL/min/1.73 m2 by the race-free CKD-EPI 1912 equation; albumin-to-creatinine ratio 286 to 294 mg/g; present for more than three months), most likely hypertensive kidney disease; bland urine sediment and normal-sized kidneys on ultrasound; 5-year kidney failure risk 1.6% | active | confirmed | N18.31 | S — Synthetic kidney findings anchored to the documented nephritis and death from kidney disease. |
| Hyperlipidemia: LDL 174 mg/dL; 10-year ASCVD risk 7.9% by the Pooled Cohort Equations (intermediate) | active | confirmed | E78.5 | S — Synthetic laboratory finding. |
Vital signs recorded on 1917-02-23; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well, articulate and engaged |
| Vital signs | Blood pressure 160/100 and pulse 80, measured by the clinic nurse today |
| Cardiovascular | Regular rhythm; sustained apex beat; no bruits |
| Extremities | No ankle swelling; no rash |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1917-02-23 | Albumin/Creatinine [Mass Ratio] in Urine | 294 | mg/g | Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3) | High | S |
| 1917-02-23 | Creatinine [Mass/volume] in Serum or Plasma | 1.21 | mg/dL | 0.59-1.04 mg/dL | High | S |
| 1917-02-23 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1912)/1.73 sq M | 55 | mL/min/{1.73_m2} | 60 or higher (G1 to G2) unless other kidney damage; 45 to 59 is G3a | Low | S |
| 1917-02-23 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1917-02-23 | Phosphate [Mass/volume] in Serum or Plasma | 3.6 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 1917-02-23 | Parathyrin.intact [Mass/volume] in Serum or Plasma | 58 | pg/mL | 15-65 pg/mL | Normal | S |
| 1917-02-23 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 31 | ng/mL | 30-100 ng/mL | Normal | S |
Data reviewed: Dr. Okonjo-Bell's intake note and results: creatinine 1.22 mg/dL, eGFR 54 at intake and 1.21 mg/dL, eGFR 55 today (CKD-EPI 1912, race-free); potassium 4.4 mmol/L; urine albumin-to-creatinine ratio 286 mg/g at intake and 294 mg/g today; urinalysis 1+ protein without blood, bland sediment; calcium 9.4 mg/dL, phosphate 3.6 mg/dL, parathyroid hormone 58 pg/mL, 25-hydroxyvitamin D 31 ng/mL; A1c 5.4%; LDL 174 mg/dL; hemoglobin 12.4 g/dL. ECG: left ventricular hypertrophy by voltage. Kidney ultrasound this morning: right kidney 10.4 cm, left 10.6 cm, normal cortical thickness, mildly increased echogenicity, no hydronephrosis, stones or cysts. Ambulatory and home readings as above; clinic 160/100 today. [S]